Add BrightSurf on Google Email

Science News for December 25, 2006


Wound botulism

Wound botulism is a potentially fatal illness caused by Clostridium botulinum spores contaminating wounds. A case study published in PLoS Medicine reports a man's full recovery after prompt diagnosis and treatment with ventilator support and botulinum antitoxin.

SourcePLOS·JournalPLOS Medicine·DateDec 25, 2006

Deaths of severely malnourished children: identifying those most at risk

A study published in PLoS Medicine identified four clinical features that can predict the likelihood of death in severely malnourished children. These signs include slow heart rate, weak pulse volume, depressed level of consciousness, and delayed capillary refilling time. The researchers proposed using these indicators to identify high...

SourcePLOS·JournalPLOS Medicine·DateDec 25, 2006

Tuberculosis risks for health workers in developing countries

A systematic review found that over half of health-care workers in low- and middle-income countries have latent TB. The disease rates among HCWs were substantially higher than those in the general population. Research is needed to determine if control measures that reduced transmission in high-income countries will work elsewhere.

SourcePLOS·JournalPLOS Medicine·DateDec 25, 2006

Prompting men to have syphilis tests

The campaign, which used humorous cartoon strips to encourage syphilis testing, was associated with an increase in syphilis tests and improved knowledge about the disease. Researchers found that awareness of the campaign led to greater knowledge about syphilis and increased recent testing for the disease.

SourcePLOS·JournalPLOS Medicine·DateDec 25, 2006

Stem cells as cancer therapy

Neural stem cells can be engineered to deliver anti-cancer drugs to metastatic cancer cells, potentially treating disseminated cancer. Researchers successfully eradicated metastases in a mouse model of neuroblastoma using this approach.

SourcePLOS·JournalPLOS Medicine·DateDec 25, 2006

Erythrocyte G protein as a novel target for malarial chemotherapy

Researchers discovered that propranolol decreases erythrocyte G protein activity and inhibits blood-stage malarial parasite growth in red blood cells. The study suggests using propranolol in combination with existing antimalarials to reduce treatment doses, providing a novel antimalarial target and potential treatment strategy.

SourcePLOS·JournalPLOS Medicine·DateDec 25, 2006